Filing Flows › Ceribell (CBLL) › Q3 2026 › vs Q3 2025
Ceribell (CBLL) Q3 2026 vs Q3 2025 (year over year)
Ceribell's revenue rose $6.8M (+30%) from $22.6M in Q3 2025 to $29.3M in Q3 2026. The biggest changes: Product +$5.2M (+31%); Subscription +$1.5M (+28%).
Ceribell, Q3 2026: revenue $29.3M (+30% year over year), operating margin -70.0%, net loss $21.4M, operating cash flow −$13.1M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product | $22.2M | $17.0M | $5.2M | +31% |
| Subscription | $7.1M | $5.6M | $1.5M | +28% |
| Revenue | $29.3M | $22.6M | $6.8M | +30% |
| Net loss | $21.4M | $13.5M | $7.9M | +59% |
| Costs & expenses | $50.7M | $37.2M | $13.5M | +36% |
| Operating costs | $49.9M | $37.2M | $12.7M | +34% |
| Interest & other, net | $803K | −$1.2M | $2.0M | — |
| Cost of revenue | $3.0M | $2.6M | $354K | +13% |
| Research & development | $7.4M | $5.0M | $2.4M | +49% |
| Sales & marketing | $25.0M | $18.6M | $6.5M | +35% |
| General & admin | $14.5M | $11.0M | $3.4M | +31% |
| Operating cash sources | $21.4M | $13.5M | $7.9M | +59% |
| Depreciation & amortization | $249K | $391K | −$142K | -36% |
| Share-based compensation | $7.1M | $3.3M | $3.8M | +112% |
| Working capital & other | $926K | −$1.4M | $2.3M | — |
| Cash used in operations | $13.1M | $11.1M | $2.0M | +18% |
| Net loss absorbed | $21.4M | $13.5M | $7.9M | +59% |
Questions
How much did Ceribell's revenue grow year over year in Q3 2026?
Ceribell's revenue rose $6.8M (+30%) from $22.6M in Q3 2025 to $29.3M in Q3 2026.
What drove Ceribell's revenue change in Q3 2026?
Product +$5.2M (+31%); Subscription +$1.5M (+28%).